Observational studyFrontiers in immunology2026
RAR and infant mortality: a crucial link in cardiac surgery outcomes.
Observational study in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In-hospital mortality remains a significant concern in infant cardiac surgery, yet precise risk stratification tools are lacking. The prognostic value of the red cell distribution width-to-albumin ratio (RAR)-a composite marker of inflammation and nutritional status-remains unestablished in this population. This study aimed to examine the association between RAR and in-hospital mortality in infants undergoing cardiac surgery. Methods: This work constitutes a retrospective observational cohort analysis. The study population comprised infants admitted to Guangdong Provincial People's Hospital for cardiac surgery from January 2017 through October 2021.The optimal cut-off value for the RAR was determined to be 1.35 fL/(g/L) using the Youden index method. Based on this threshold, all participants were categorized into a high-RAR group and a low-RAR group. The relationship between RAR levels and mortality during hospitalization was then examined through multiple analytical approaches, including logistic regression, subgroup analyses, and modeling with restricted cubic splines (RCS).The predictive performance of the RAR was further evaluated through an analysis of the receiver operating characteristic (ROC) curve. Results: Mortality rates in this surgical cohort increased with higher RAR values. A consistent relationship linking the RAR to mortality was observed regardless of whether this biomarker was incorporated into statistical models as a continuous measure or a categorical parameter. Among 3634 patients, logistic regression analysis indicated that infants with RAR > 1.35 fL/(g/L) had a significantly higher mortality risk compared to those with RAR ≤ 1.35 fL/(g/L) (OR = 2.16, 95% CI 1.01-4.60, p < 0.05). Furthermore, the direction of the association was consistent across subgroups. The predictive performance of the model was good, with an area under the ROC curve of 0.8. Conclusion: A higher RAR-specifically a value above 1.35 fL/(g/L)-was associated with increased mortality risk during hospitalization in infants undergoing cardiac surgery. As an easily measurable blood-based indicator, RAR demonstrates potential value for clinical practice and research applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.